Structure-Based Pharmacophore Models Generation and Combinatorial Screening of ICE Inhibitors

Abstract:

Eight structure-based pharmacophore models of Interleukin-1β converting enzyme (ICE) inhibitors were generated by LigandScout based on ICE inhibitor complexes from the Protein Data Bank (PDB). A combinatorial screening method based on multiple pharmacophore models were proposed in present study, since the binding pockets of different complexes were different, the structure-based pharmacophore models have a high specificity and cannot cover all the active molecules. Based on the screening results of MDDR and the metrics of E and A%, a new metric CAI (comprehensive appraisal index) was defined and used to determine the threshold of hit frequency of molecules which screened by the combinatorial screening method. According to the threshold, the potential ICE inhibitors were then identified from traditional Chinese medicine with the method of combinatorial screening with eight models. The molecules hit by not less than five pharmacophore models were taken as the screening objects of ICE inhibitor, and 781 molecules were obtained.

• Periodical: Applied Mechanics and Materials (Volumes 347-350)
• Pages: 1216-1220
• DOI: https://doi.org/10.4028/www.scientific.net/AMM.347-350.1216
• Online since: August 2013
• Authors: Yan Ling Zhang, Yuan Ming Wang, Yan Jiang Qiao
• Keywords: Combinatorial Screening of Multiple Pharmacophores, Comprehensive Appraisal Index, Identification from Chinese Herbs, Interleukin-1β Convertingenzyme, Structure-Based Pharmacophore

References

[1] Judith M. Rollinger, Sabine Haupt, Hermann Stuppner, and Thierry Langer, Combining Ethnopharmacology and Virtual Screening for Lead Structure Discovery: COX-Inhibitors as Application Example, J. Chem. Inf. Comput. Sci., vol. 44, 2004, pp.480-488.

DOI: 10.1021/ci030031o

[2] Yili W., Steven V.O., John A.W., etc., Synthesis and evaluation of unsaturated caprolactams as interleukin-1ß converting enzyme (ICE) inhibitors, Bioorganic & Medicinal Chemistry, vol. 15, 2007, pp.1311-1322.

DOI: 10.1016/j.bmc.2006.11.011

[3] Stephan G., Bernd L.H., Klaus K., The interleukin 1ß-converting enzyme inhibitor CrmA prevents Apl1/Fas- but not glucocorticoid-induced poly (ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia celss, FEBS letters, vol. 402, 1997, pp.36-40.

DOI: 10.1016/s0014-5793(96)01496-2

[4] Osman FG., Pharmacophore perception, development, and use in drug design, 1st ed., California: InternationalUniversity Line, 2000, p.197.

[5] Thierry L and Remy DH, Pharmacophoresand pharmacophore searchs, volume 32, Wiley-VCH, 2006, pp.338-339.